Specificity and completeness of inhibition of DNA repair by novobiocin and aphidicolin.
Novobiocin and aphidicolin were both potent inhibitors of excision repair of u.v.-induced damage to DNA in human embryonic fibroblasts, and both also inhibited semiconservative DNA replication even more strongly. The mechanism of action of these two drugs is, however, different. Novobiocin inhibited repair replication without accumulating single-strand breaks, but aphidicolin inhibited repair replication with the accumulation of numerous single-strand breaks. Novobiocin appears to inhibit repair at an earlier stage than aphidicolin, which may indicate that DNA topoisomerases play a role in eukaryotic DNA repair. Digestion of DNA by exonuclease III indicated that repair patches in novobiocin-treated cells contained no excess 3'OH termini, whereas up to 40% of the repaired DNA in aphidicolin-treated cells had free 3'OH termini. Therefore, although aphidicolin resulted in the accumulation of single-strand breaks, many of the repair events escaped inhibition and the number of breaks is an underestimate of the true number of repair events.
D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D016590:Aphidicolin; D002460:Cell Line; D004247:DNA / Q000528:radiation effects; D004260:DNA Repair / Q000187:drug effects*; D004261:DNA Replication / Q000187:drug effects*; D004224:Diterpenes / Q000494:pharmacology*; D004622:Embryo, Mammalian; D005260:Female; D005347:Fibroblasts; D006801:Humans; D007700:Kinetics; D009675:Novobiocin / Q000494:pharmacology*; D011247:Pregnancy; D014466:Ultraviolet Rays
D000903:Antibiotics, Antineoplastic; D004224:Diterpenes; D009675:Novobiocin; D016590:Aphidicolin; D004247:DNA